Suppr超能文献

结直肠癌筛查:对近期非侵入性方法的全面综述。

Colorectal Cancer Screening: A Comprehensive Review to Recent Non-Invasive Methods.

作者信息

Hamzehzadeh Leila, Yousefi Meysam, Ghaffari Seyed-Hamidollah

机构信息

Department of Medical Genetics, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

Hematology, Oncology and Stem Cell Transplantation Research Center, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.

出版信息

Int J Hematol Oncol Stem Cell Res. 2017 Jul 1;11(3):250-261.

Abstract

Colorectal cancer (CRC) is one of the most common cancers worldwide and considered to be one of the hassles in medical communities. CRC develops from precancerous polyps in the colon or rectum and is preventable and curable by an early diagnosis and with the removal of premalignant polyps. In recent years, scientists have looked for inexpensive and safe ways to detect CRC in its earliest stages. Strong evidence shows that screening for CRC is a crucial way to reduce the incidence and mortality of this devastating disease. The main purpose for screening is to detect cancer or pre-cancer signs in all asymptomatic patients. In this review, we holistically introduce major pathways involved in the initiation and progression of colorectal tumorgenesis, which mainly includes chromosome instability (CIN), microsatellite instability (MSI), the CpG island methylator phenotype (CIMP), and we then will discuss different screening tests and especially the latest non-invasive fecal screening test kits for the detection of CRC.

摘要

结直肠癌(CRC)是全球最常见的癌症之一,被认为是医学界的难题之一。CRC由结肠或直肠中的癌前息肉发展而来,通过早期诊断和切除癌前息肉是可预防和治愈的。近年来,科学家们一直在寻找廉价且安全的方法来在CRC的最早阶段进行检测。有力证据表明,CRC筛查是降低这种毁灭性疾病发病率和死亡率的关键方法。筛查的主要目的是在所有无症状患者中检测癌症或癌前迹象。在本综述中,我们全面介绍了结直肠肿瘤发生起始和进展所涉及的主要途径,主要包括染色体不稳定(CIN)、微卫星不稳定(MSI)、CpG岛甲基化表型(CIMP),然后我们将讨论不同的筛查测试,尤其是用于检测CRC的最新非侵入性粪便筛查测试试剂盒。

相似文献

1
Colorectal Cancer Screening: A Comprehensive Review to Recent Non-Invasive Methods.
Int J Hematol Oncol Stem Cell Res. 2017 Jul 1;11(3):250-261.
3
Microsatellite instability in colorectal cancer.
EXCLI J. 2018 Jan 22;17:159-168. doi: 10.17179/excli2017-948. eCollection 2018.
4
The CpG island methylator phenotype (CIMP) in colorectal cancer.
Gastroenterol Hepatol Bed Bench. 2013 Summer;6(3):120-8.
5
Methylator phenotype in colorectal cancer: A prognostic factor or not?
Crit Rev Oncol Hematol. 2016 Mar;99:74-80. doi: 10.1016/j.critrevonc.2015.11.001. Epub 2015 Dec 7.
8
The CpG island methylator phenotype and chromosomal instability are inversely correlated in sporadic colorectal cancer.
Gastroenterology. 2007 Jan;132(1):127-38. doi: 10.1053/j.gastro.2006.09.018. Epub 2006 Sep 20.
10
No association of CpG island methylator phenotype and colorectal cancer survival: population-based study.
Br J Cancer. 2016 Nov 22;115(11):1359-1366. doi: 10.1038/bjc.2016.361. Epub 2016 Nov 3.

引用本文的文献

1
Dynamic liquid biopsy components as predictive and prognostic biomarkers in colorectal cancer.
J Exp Clin Cancer Res. 2022 Mar 15;41(1):99. doi: 10.1186/s13046-022-02318-0.
2
Cannabinoids, Medical Cannabis, and Colorectal Cancer Immunotherapy.
Front Med (Lausanne). 2021 Sep 24;8:713153. doi: 10.3389/fmed.2021.713153. eCollection 2021.
3
Gold nanoparticles enhance microRNA 31 detection in colon cancer cells after inhibition with chlorogenic acid.
Oncol Lett. 2021 Oct;22(4):742. doi: 10.3892/ol.2021.13003. Epub 2021 Aug 19.
4
Cost-Effectiveness of Colorectal Cancer Genetic Testing.
Int J Environ Res Public Health. 2021 Aug 6;18(16):8330. doi: 10.3390/ijerph18168330.
5
Alterations in Gene Expression of Renin-Angiotensin System Components and Related Proteins in Colorectal Cancer.
J Renin Angiotensin Aldosterone Syst. 2021 Jul 5;2021:9987115. doi: 10.1155/2021/9987115. eCollection 2021.
6
miRNA Clusters with Up-Regulated Expression in Colorectal Cancer.
Cancers (Basel). 2021 Jun 14;13(12):2979. doi: 10.3390/cancers13122979.
7
Updates on Clinical Use of Liquid Biopsy in Colorectal Cancer Screening, Diagnosis, Follow-Up, and Treatment Guidance.
Front Cell Dev Biol. 2021 May 24;9:660924. doi: 10.3389/fcell.2021.660924. eCollection 2021.
9
Non-Invasive Colorectal Cancer Screening: An Overview.
Gastrointest Tumors. 2020 Jul;7(3):62-73. doi: 10.1159/000507701. Epub 2020 May 20.

本文引用的文献

1
Colorectal cancer statistics, 2017.
CA Cancer J Clin. 2017 May 6;67(3):177-193. doi: 10.3322/caac.21395. Epub 2017 Mar 1.
3
Colorectal Cancer Biomarkers: Where Are We Now?
Biomed Res Int. 2015;2015:149014. doi: 10.1155/2015/149014. Epub 2015 May 27.
4
Molecular markers for colorectal cancer screening.
Gut. 2015 Sep;64(9):1485-94. doi: 10.1136/gutjnl-2014-308075. Epub 2015 May 20.
6
Quantitative detection of methylated NDRG4 gene as a candidate biomarker for diagnosis of colorectal cancer.
Oncol Lett. 2015 Mar;9(3):1383-1387. doi: 10.3892/ol.2014.2815. Epub 2014 Dec 19.
7
Cancer statistics, 2015.
CA Cancer J Clin. 2015 Jan-Feb;65(1):5-29. doi: 10.3322/caac.21254. Epub 2015 Jan 5.
8
Fecal occult blood testing as a diagnostic test in symptomatic patients is not useful: a retrospective chart review.
Can J Gastroenterol Hepatol. 2014 Sep;28(8):421-6. doi: 10.1155/2014/189652. Epub 2014 Jul 11.
9
Multitarget stool DNA testing for colorectal-cancer screening.
N Engl J Med. 2014 Apr 3;370(14):1287-97. doi: 10.1056/NEJMoa1311194. Epub 2014 Mar 19.
10
Role of targeted agents in metastatic colorectal cancer.
Target Oncol. 2013 Jun;8(2):83-96. doi: 10.1007/s11523-013-0281-x. Epub 2013 May 5.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验